US Stock MarketDetailed Quotes
GLMD Galmed Pharmaceuticals
- 3.2400
- -0.1000-2.99%
Close Nov 1 16:00 ET
4.88MMarket Cap-310P/E (TTM)
3.3800High3.1000Low67.60KVolume3.3400Open3.3400Pre Close219.04KTurnover4.54%Turnover RatioLossP/E (Static)1.51MShares23.800052wk High0.41P/B4.82MFloat Cap2.730052wk Low--Dividend TTM1.49MShs Float4870.8000Historical High--Div YieldTTM8.38%Amplitude2.7300Historical Low3.2400Avg Price1Lot Size
Galmed Pharmaceuticals Key Stats
EPS
According to the latest financial report of Galmed Pharmaceuticals, the latest earnings per share (TTM) for the company is -2.16. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Galmed Pharmaceuticals's free cash flow? The latest report shows it as -1.02M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Galmed Pharmaceuticals shows that the company's current ratio is 6.48, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Galmed Pharmaceuticals, the quick ratio is 6.41, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Galmed Pharmaceuticals? The latest ROE figure is -9.12%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Galmed Pharmaceuticals, the total asset return on investment (ROA) is -8.03%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Galmed Pharmaceuticals's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Galmed Pharmaceuticals, the net profit margin is -63.93%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data